000 01446 a2200457 4500
005 20250513122813.0
264 0 _c19970825
008 199708s 0 0 eng d
022 _a0952-0600
024 7 _a10.1006/pulp.1996.0039
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aParvez, L
245 0 0 _aEvaluation of antitussive agents in man.
_h[electronic resource]
260 _bPulmonary pharmacology
_c
300 _a299-308 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAcute Disease
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntitussive Agents
_xtherapeutic use
650 0 4 _aBromhexine
_xtherapeutic use
650 0 4 _aChronic Disease
650 0 4 _aCough
_xdrug therapy
650 0 4 _aDextromethorphan
_xtherapeutic use
650 0 4 _aDouble-Blind Method
650 0 4 _aExpectorants
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aGuaifenesin
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRespiratory Tract Infections
_xcomplications
650 0 4 _aTime Factors
700 1 _aVaidya, M
700 1 _aSakhardande, A
700 1 _aSubburaj, S
700 1 _aRajagopalan, T G
773 0 _tPulmonary pharmacology
_gvol. 9
_gno. 5-6
_gp. 299-308
856 4 0 _uhttps://doi.org/10.1006/pulp.1996.0039
_zAvailable from publisher's website
999 _c9212866
_d9212866